New Report Just Published: World Multiple Myeloma Therapeutics Market Report

...alignancies II-54 GlaxoSmithKline to Take Over Praecis Pharmaceuticals II-54 Biotest Acquires ImmunoGen Anticancer Technology Rights II-54 hana Signs Licensing Agreement with Inex II-54 Cephalon Acquires Zeneus II-54 5. Focus on Select Players II-55 Amgen Inc (USA) II-55 Avalo...

New edition of the Tobacco Atlas catalogues catastrophic toll of tobacco worldwide

...ior Advisor to the World Health Organisation (WHO), and was director of the Centers for Disease Control and Prevention's Office on Smoking and Health. hana Ross, Ph.D. is an economist and strategic director of international tobacco control research at the American Cancer Society. She is also deputy direc...

Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results

.... In August, the Company acquired the North American commercial rights from hana Biosciences, Inc. ("HANA") for Zensana(TM), at which time the Company made a $5.0 million equity investment in hana at a contractually agreed premium. Of this amount, $1.2 million representin...

Par Pharmaceutical Reports Third-Quarter 2007 Results

.... In August, the Company acquired the North American commercial rights from hana Biosciences, Inc. ("HANA") for Zensana(TM), at which time the Company made a $5.0 million equity investment in hana at a contractually agreed premium. Of this amount, $1.2 million representin...

HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...asdaq: IDEV Neuroscience Drop Schwarz Pharma AG Xetra: SRZ GY Add Forest Laboratories, Inc. NYSE: FRX Emerging Cancer Drop hana Bioscience, Inc. Nasdaq: HNAB Axcan Pharma, Inc. Nasdaq: AXCA Isis Pharmaceuticals Nasdaq: ISIS ...

Women in Iraq More Unsafe Than Ever

... the uncle and at least two cousins abducted her from the priest's custody. "There is a new Taliban controlling the lives of women in Iraq," said hana Edwar, the leader of the Amal Organisation for Women in Baghdad. "I think this story will be absolutely repeated again." Kurds who had suffe...

Tooth-Whitening Products Work for Brightening Smiles in Short Term

...e, rest assured: a new review of existing research suggests there's a good chance they’re effective. // "All the products seem to work," said Dr. hana Hasson, clinical associate professor at the University of Michigan and lead author of the review. "They were dependable in terms of effects and safety...

More>>

Hana in Medical Technology

Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia

...ANCISCO, Calif., March 3 /PRNewswire-FirstCall/ -- hana Biosciences (Nasdaq: HNAB ) today announced new ...tine without increased toxicity." Yesterday, hana Biosciences announced the findings from a planned,...nada, Germany, Israel and the United Kingdom. hana Biosciences has received orphan drug and fast trac...

Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound

... M.D., vice president and chief medical officer of hana Biosciences. "Thanks to our enthusiastic and commi...da, Germany, Israel and the United Kingdom. hana Biosciences has received orphan drug and fast trac...early dose-limiting neurotoxicities. About hana Biosciences, Inc. ...

Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting

...tion for Talvesta in patients with ALL. About hana Biosciences, Inc. hana Biosciences, Inc. (Nasdaq:HNAB) is a South San Fra... unique company culture. Additional information on hana Biosciences can be found at

Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting

...EGFR inhibitors," stated Steven R. Deitcher, M.D., hana Bioscience's Executive Vice President of Developme... Menadione is a topical agent being developed by hana to treat skin rashes associated with use of Epider...ent activity against Stage IV metastatic melanoma. hana is currently developing Marqibo for use in the tre...

Hana in Biological Technology

ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer

...ies: Metrika, Inc., a privately held diagnostics company, and three public biotechnology companies, Progenitor, Inc., Somatix Therapy Corporation, and hana Biologics, Inc. In addition he is a co-founder and director of the Association of Bioscience Financial Officers, an international organization of life...

ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board

...rofessor and Chair, Science & Technology Entrepreneurship at Victoria University of Wellington in New Zealand. Previously, he was President and CEO of hana Biosciences, Inc. and Vice President of Hematology at Genentech, Inc. "Mark's expert understanding of drug discovery, development and commercializat...

Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products

...rth American commercial rights to Zensana(TM) from hana Biosciences, Inc. Ondansetron is used to prevent n...$5 million equity investment in Hana. In addition, hana may receive future milestone payments and royaltie...formation, visit http://www.novadel.com . About hana Biosciences ...

Introducing Strativa Pharmaceuticals

... $75 million. Strativa currently also has three Phase III in-licensed supportive care drugs in its pipeline: -- Zensana(TM) (ondansetron HCl) (with hana Biosciences, Inc) is being studied for the prevention of nausea and vomiting after chemotherapy, radiation and surgery. Following approval,...